Institutional Ownership
Global Cord Blood Corp
CUSIP G39342103COMQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
64.9%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest May 15, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | May 15, 2025 | Oasis Management Company Ltd | 13G/A | 13.0% | 17.39M | SEC |
| 2 | Mar 11, 2024 | Oasis Management Co Ltd. | 13G/A | 10.1% | 13.58M | SEC |
| 3 | Feb 14, 2024 | Oasis Management Co Ltd. | 13G/A | 9.9% | 13.27M | SEC |
| 4 | Feb 14, 2023 | Oasis Management Co Ltd. | 13G | 5.6% | 6.80M | SEC |
| 5 | Feb 3, 2023 | Jayhawk Capital Management, L.L.C. | 13G/A | 4.7% | 5.72M | SEC |
| 6 | Feb 3, 2023 | Pacific Alliance Group Ltd | 13G | 7.8% | 9.50M | SEC |
| 7 | May 31, 2022 | Golden Meditech Stem Cells (Bvi) Co Ltd | 13D/A | 64.9% | 78.87M | SEC |
| 8 | May 23, 2022 | Golden Meditech Stem Cells (Bvi) Co Ltd | 13D | 64.9% | 78.87M | SEC |
| 9 | Feb 15, 2022 | Jayhawk Capital Management, L.L.C. | 13G/A | — | — | SEC |
| 10 | Feb 11, 2021 | Jayhawk Capital Management, L.L.C. | 13G/A | 9.9% | 12.00M | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Global Cord Blood Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rhumbline Advisers | 13.4K | $14.0K |